111 related articles for article (PubMed ID: 3407033)
1. Percutaneous treatment of transitional cell carcinoma of the upper urinary tract.
Orihuela E; Smith AD
Urol Clin North Am; 1988 Aug; 15(3):425-31. PubMed ID: 3407033
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
Goel MC; Mahendra V; Roberts JG
J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
[TBL] [Abstract][Full Text] [Related]
3. [Laser coagulation treatment of urothelial tumors of the upper urogenital tract with the Nd:-YAG laser].
Theodorakis J; Klammert R; Kriegmair M
Urologe A; 1994 Jul; 33(4):303-7. PubMed ID: 7941177
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome.
Jabbour ME; Desgrandchamps F; Cazin S; Teillac P; Le Duc A; Smith AD
J Urol; 2000 Apr; 163(4):1105-7; quiz 1295. PubMed ID: 10737475
[TBL] [Abstract][Full Text] [Related]
5. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Chen GL; Bagley DH
J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience.
Jarrett TW; Sweetser PM; Weiss GH; Smith AD
J Urol; 1995 Nov; 154(5):1629-35. PubMed ID: 7563308
[TBL] [Abstract][Full Text] [Related]
8. [Definitive endourological treatment in urothelial tumors of the upper urinary tract].
Rodríguez Rodríguez R; Fernández González I; Galbis Sanjuan F; Fernández Fernández E; Escudero Barrilero A; Lovaco Castellanos F
Arch Esp Urol; 1995 Nov; 48(9):937-43. PubMed ID: 8554399
[TBL] [Abstract][Full Text] [Related]
9. 13-year experience with percutaneous management of upper tract transitional cell carcinoma.
Clark PE; Streem SB; Geisinger MA
J Urol; 1999 Mar; 161(3):772-5; discussion 775-6. PubMed ID: 10022682
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma.
Elliott DS; Blute ML; Patterson DE; Bergstralh EJ; Segura JW
Urology; 1996 Jun; 47(6):819-25. PubMed ID: 8677570
[TBL] [Abstract][Full Text] [Related]
11. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.
Boorjian S; Ng C; Munver R; Palese MA; Vaughan ED; Sosa RE; Del Pizzo JJ; Scherr DS
Urology; 2005 Aug; 66(2):283-7. PubMed ID: 16098357
[TBL] [Abstract][Full Text] [Related]
12. [Intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma].
Mori H; Miyaji B; Takahashi M; Matsuda K; Tsuka H; Wada O; Aoki Y; Akino H; Muranaka K; Kanamaru H; Okada K; Imamura Y
Hinyokika Kiyo; 1996 Apr; 42(4):257-61. PubMed ID: 8693956
[TBL] [Abstract][Full Text] [Related]
13. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma.
Keeley FX; Bibbo M; Bagley DH
J Urol; 1997 May; 157(5):1560-5. PubMed ID: 9112476
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience.
Daneshmand S; Quek ML; Huffman JL
Cancer; 2003 Jul; 98(1):55-60. PubMed ID: 12833455
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic management of upper tract urothelial tumors.
Stoller ML; Gentle DL; McDonald MW; Reese JH; Tacker JR; Carroll PR; Best C
Tech Urol; 1997; 3(3):152-7. PubMed ID: 9422447
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous management of renal pelvic tumors: a treatment option in selected cases.
Smith AD; Orihuela E; Crowley AR
J Urol; 1987 May; 137(5):852-6. PubMed ID: 3106652
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous management of upper-tract transitional cell carcinoma.
Streem SB
Urol Clin North Am; 1995 Feb; 22(1):221-9. PubMed ID: 7855957
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
Urology; 2008 Apr; 71(4):713-7. PubMed ID: 18267338
[TBL] [Abstract][Full Text] [Related]
19. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
20. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
